Xponance’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.3K Buy
25,413
+7,097
+39% +$18.2K ﹤0.01% 1616
2025
Q4
$61.2K Buy
18,316
+985
+6% +$3.5K ﹤0.01% 1507
2025
Q3
$66.4K Sell
17,331
-72
-0.4% -$302 ﹤0.01% 1468
2025
Q2
$74.8K Sell
17,403
-2,090
-11% -$8.42K ﹤0.01% 1433
2025
Q1
$76.6K Buy
19,493
+1,271
+7% +$6.02K ﹤0.01% 1369
2024
Q4
$92.6K Buy
18,222
+2,689
+17% +$15.5K ﹤0.01% 1374
2024
Q3
$110K Buy
15,533
+703
+5% +$4.48K ﹤0.01% 1309
2024
Q2
$84.4K Sell
14,830
-1,919
-11% -$12.2K ﹤0.01% 1252
2024
Q1
$124K Sell
16,749
-35
-0.2% -$292 ﹤0.01% 1227
2023
Q4
$155K Sell
16,784
-162
-1% -$1.2K ﹤0.01% 1183
2023
Q3
$114K Buy
16,946
+298
+2% +$2.38K ﹤0.01% 1159
2023
Q2
$159K Buy
16,648
+33
+0.2% +$280 ﹤0.01% 1163
2023
Q1
$156K Buy
16,615
+155
+0.9% +$1.6K ﹤0.01% 1139
2022
Q4
$137K Buy
+16,460
New +$155K ﹤0.01% 1142

Other funds holding CLVT

Xponance's CLVT Position: Q1 2026 in Review

Xponance increased its Clarivate (CLVT) stake by 39% in Q1 2026, buying an estimated $18.2K and bringing the position to 25,413 shares worth $64.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1616.

Xponance first reported a position in CLVT in Q4 2022 and has held it in 14 quarters since. The position peaked at $159K in Q2 2023. 254 funds tracked by Wall St. Rank hold CLVT as of Q1 2026.

  • Xponance held 25,413 shares of Clarivate worth $64.3K as of Q1 2026.
  • Xponance bought 7,097 Clarivate shares in Q1 2026, an estimated $18.2K.
  • Clarivate made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1616 holding.
  • Xponance first reported a position in Clarivate in Q4 2022 and has held it in 14 quarters since.
  • Xponance's Clarivate position peaked at $159K in Q2 2023.
  • 254 funds tracked by Wall St. Rank held Clarivate as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.